Is Sodium Heparin safe in cosmetics?
Sodium Heparin has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted. 8 toxicological study endpoint(s) are available in our database.
Also known as: Heparin, sodium salt, Adomiparin sodium, Dalteparin sodium, Deligoparin sodium, Liquaemin sodium (+12 more)
INCI: SODIUM HEPARIN
Sodium Heparin (CAS 9041-08-1) is a cosmetic cosmetic ingredient functioning as Skin conditioning. Reported NOAEL =4 mg/kg bw/day in rat (Sprague-Dawley; male/female) (FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z); EU Regulation 1223/2009 status: permitted. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in pharmaceutical data.
View industrial chemical safety profile for CAS 9041-08-1 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Sodium Heparin.
Calculate MoS for your specific formulation with the MoS Calculator.
8 study endpoints found for Sodium Heparin. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =4 mg/kg bw/day | subcutaneous | rat (Sprague-Dawley; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =4 mg/kg bw/day | subcutaneous | rat (Sprague-Dawley; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =4 mg/kg bw/day | subcutaneous | rat (Sprague-Dawley; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =4 mg/kg bw/day | subcutaneous | rat (Sprague-Dawley; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =10 mg/kg bw/day | subcutaneous | dog (Beagle; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =10 mg/kg bw/day | subcutaneous | dog (Beagle; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =10 mg/kg bw/day | subcutaneous | dog (Beagle; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
| NOAEL | =10 mg/kg bw/day | subcutaneous | dog (Beagle; male/female) | repeated dose toxicity other | FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z |
Expert safety assessment and concern-level summary for Sodium Heparin.
Public NOAEL study rows linked to Sodium Heparin by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Sodium Heparin has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted. 8 toxicological study endpoint(s) are available in our database.
Sodium Heparin EU regulatory status: permitted. This is based on EU Regulation 1223/2009 and its amendments.
Sodium Heparin functions as: Skin conditioning. It is classified as a cosmetic ingredient in our database. CAS number: 9041-08-1.
The NOAEL (No Observed Adverse Effect Level) for Sodium Heparin is =4 mg/kg bw/day based on a repeated dose toxicity other study via subcutaneous route in rat (Sprague-Dawley; male/female). A total of 8 study endpoints are available. Source: FDA_Toxicity_040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z.
Sodium Heparin also appears in pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Sodium Heparin compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Sodium Heparin in your formulation.